
|Articles|August 2, 2002
- Pharmaceutical Technology-08-02-2002
- Volume 26
- Issue 8
Risk Management Shapes FDA Policies and Practices
Author(s)Jill Wechsler
In response to increasing concern about drug safety, FDA has implemented several administrative and policy changes, inclduing the new Office of Pharmacoepidemiology and Statistical Science and a renewed focus on risk assessment.
Advertisement
Articles in this issue
about 23 years ago
Packaging Advances ShowcasedNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
5





